Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
AFFIBODY (R) MOLECULES AS NEW POTENTIAL AGENTS FOR RADIONUCLIDE IMAGING AND THERAPY
Affibody AB, SE-16102 Bromma, Sweden..
Affibody AB, SE-16102 Bromma, Sweden..
Affibody AB, SE-16102 Bromma, Sweden..
KTH.
Show others and affiliations
2004 (English)In: Anticancer Research, ISSN 0250-7005, E-ISSN 1791-7530, Vol. 24, no 5D, p. 3686-3686Article in journal, Meeting abstract (Other academic) Published
Place, publisher, year, edition, pages
INT INST ANTICANCER RESEARCH , 2004. Vol. 24, no 5D, p. 3686-3686
National Category
Biological Sciences
Identifiers
URN: urn:nbn:se:kth:diva-242513ISI: 000205415300582OAI: oai:DiVA.org:kth-242513DiVA, id: diva2:1285349
Note

QC 20190204

Available from: 2019-02-04 Created: 2019-02-04 Last updated: 2019-02-04Bibliographically approved

Open Access in DiVA

No full text in DiVA

Authority records BETA

Ståhl, Stefan

Search in DiVA

By author/editor
Wikman, MariaStåhl, Stefan
By organisation
KTHBiotechnology
In the same journal
Anticancer Research
Biological Sciences

Search outside of DiVA

GoogleGoogle Scholar

urn-nbn

Altmetric score

urn-nbn
Total: 8 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf